MAPLE GROVE, Minn. — Upsher-Smith Laboratories on Wednesday announced the launch of testosterone gel (1%), the generic of Vogelxo (testosterone) gel 1%, for topical use. Newly approved by the Food and Drug Administration, it is the first and only available generic testosterone replacement therapy available in three configurations, the company stated. Testosterone Gel (1%) offers once-daily dosing, 24-hour coverage and three configurations: unit-dose tubes and packets and metered-dose pumps.
Vogelxo and testosterone gel are a prescription medicine that contains testosterone. Vogelxo and testosterone gel are used to treat adult males who have low or no testosterone and those with conditions associated with low or no testosterone.
"The generic availability of testosterone gel in three convenient configurations is an important advance in the testosterone replacement therapy marketplace and should greatly increase access for the patients who need it," said Mark Evenstad, president and CEO of Upsher-Smith.
According to the American Urological Association, 39% of men older than 45 years of age have low testosterone, but few are being treated.